Expert Statement Regarding the Use of Moderna COVID-19-mRNA-Vaccine in Children

This expert statement prepared by Michael Palmer MD and Sucharit Bhakdi MD was submitted by Italian lawyer Renate Holzeisen in conjunction with a lawsuit that challenges the EU’s authorization of the use of Moderna’s mRNA vaccine on children of 12 years and older. The Pfizer vaccine was addressed in a previously published expertise. Many of the arguments below—particularly those related to the dangers of expressing the biologically active SARS-CoV-2 spike protein in the human body—apply also to the adenovector-based AstraZeneca and Johnson & Johnson vaccines.

Published by markskidmore

Mark Skidmore is Professor of Economics at Michigan State University where he holds the Morris Chair in State and Local Government Finance and Policy. His research focuses on topics in public finance, regional economics, and the economics of natural disasters. Mark created the Lighthouse Economics website and blog to share economic research and information relevant for navigating tumultuous times.

Leave a Reply

%d